AI assistant
Sending…
ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2009
Aug 20, 2009
31071_dirs_2009-08-20_31b06958-3dcb-4288-9235-d6db6e33eed8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2009-03-26
Reporting Person: RAHN LEROY T (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-03-26 | Stock Option | $0.49 | A | 40000 | Acquired | 2019-03-26 | Common Stock (40000) | Direct |
More from ARROWHEAD PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Report Publication Announcement
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Apr 28
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 20
Interim / Quarterly Report
2026
Feb 5